Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™) (Q33812170)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™) |
scientific article |
Statements
1 reference
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™) (English)
1 reference
Odd Erik Johansen
1 reference
Bernard Zinman
1 reference
Silvio E Inzucchi
1 reference
Christoph Wanner
1 reference
Roberto Ferrari
1 reference
David Fitchett
1 reference
Erich Bluhmki
1 reference
Stefan Hantel
1 reference
Joan Kempthorne-Rawson
1 reference
Jennifer Newman
1 reference
Hans-Juergen Woerle
1 reference
Uli C Broedl
1 reference
19 June 2014
1 reference
1 reference
13
1 reference
102
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference